Home » Topics » Regulatory » Patents

Patents
RSS

Novel p38alpha MAPK inhibitors in development at Xcovery

Jan. 23, 2009

Mitsubishi Tanabe Pharma claims novel amine compounds for autoimmune diseases

Jan. 23, 2009

New JAK inhibitors prepared and tested at Merck & Co.

Jan. 23, 2009

Merck & Co. divulge new gamma-secretase modulators for Alzheimer's disease

Jan. 22, 2009

Novel mGluR5 receptor modulators with antipsychotic properties developed at GSK

Jan. 22, 2009

Kyorin scientists describe new antibacterial mutilin derivatives

Jan. 22, 2009

Recent Roche patent reports new antipsychotic tachykinin NK3 receptor antagonists

Jan. 22, 2009

Novel P2X7 receptor antagonists jointly discovered by AMRI and Schering-Plough researchers

Jan. 22, 2009

Bayer divulges new coagulation factor Xa and thrombin inhibitors for thromboembolic disorders

Jan. 21, 2009

New reverse transcriptase inhibitors for HIV presented in recent GSK patent

Jan. 21, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Recombinant vaccine inhibits HBV-associated HCC growth
BioWorld Science
Chronic liver disease and hepatocellular carcinoma (HCC) associated with chronic hepatitis B virus (HBV) are serious health problems in highly endemic areas....